scholarly journals Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance

2021 ◽  
Vol 1 ◽  
Author(s):  
Albert Orock ◽  
Tian Yuan ◽  
Beverley Greenwood-Van Meerveld

Chronic visceral pain represents a major unmet clinical need with the severity of pain ranging from mild to so severe as to prevent individuals from participating in day-to-day activities and detrimentally affecting their quality of life. Although chronic visceral pain can be multifactorial with many different biological and psychological systems contributing to the onset and severity of symptoms, one of the major triggers for visceral pain is the exposure to emotional and physical stress. Chronic visceral pain that is worsened by stress is a hallmark feature of functional gastrointestinal disorders such as irritable bowel syndrome (IBS). Current pharmacological interventions for patients with chronic visceral pain generally lack efficacy and many are fraught with unwanted side effects. Cognitive behavioral therapy (CBT) has emerged as a psychotherapy that shows efficacy at ameliorating stress-induced chronic visceral pain; however, the molecular mechanisms underlying CBT remain incompletely understood. Preclinical studies in experimental models of stress-induced visceral pain employing environmental enrichment (EE) as an animal model surrogate for CBT are unraveling the mechanism by which environmental signals can lead to long-lasting changes in gene expression and behavior. Evidence suggests that EE signaling interacts with stress and nociceptive signaling. This review will (1) critically evaluate the behavioral and molecular changes that lead to chronic pain in IBS, (2) summarize the pharmacological and non-pharmacological approaches used to treat IBS patients, and (3) provide experimental evidence supporting the potential mechanisms by which CBT ameliorates stress-induced visceral pain.

2020 ◽  
Vol 21 (22) ◽  
pp. 8664
Author(s):  
Yoshiyuki Mishima ◽  
Shunji Ishihara

Irritable bowel syndrome (IBS) is one of the most prevalent functional gastrointestinal disorders, and accumulating evidence gained in both preclinical and clinical studies indicate the involvement of enteric microbiota in its pathogenesis. Gut resident microbiota appear to influence brain activity through the enteric nervous system, while their composition and function are affected by the central nervous system. Based on these results, the term “brain–gut–microbiome axis” has been proposed and enteric microbiota have become a potential therapeutic target in IBS cases. However, details regarding the microbe-related pathophysiology of IBS remain elusive. This review summarizes the existing knowledge of molecular mechanisms in the pathogenesis of IBS as well as recent progress related to microbiome-derived neurotransmitters, compounds, metabolites, neuroendocrine factors, and enzymes.


Author(s):  
Yasser Al Omran ◽  
Qasim Aziz

Throughout history, symptoms of nausea, vomiting, constipation, diarrhoea, bloating, and pain have been described in relation to diseases of the gastrointestinal tract. Gastrointestinal disorders that give rise to these symptoms are broadly characterized as one of two types: structural or functional. Although structural diseases can be easily identified, and even cured by means of medical or surgical intervention, functional gastrointestinal disorders (FGIDs) remain a medical enigma. Irritable bowel syndrome (IBS) constitutes one of the 40 or so conditions under the FGIDs umbrella. It is characterized by abdominal pain and altered bowel habits and has an estimated prevalence of 5%–20% in the Western world. Around 40 years ago, little was known about the mechanism behind visceral pain in IBS. Ritchie’s landmark study was one of the first to begin to elucidate some of the mechanisms involved (and therefore provide some insight into putative treatments) in the difficult area of FGIDs.


Author(s):  
Maria Giuliana Vannucchi ◽  
Stefano Evangelista

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases in humans. It is characterized by visceral pain and/or discomfort, hypersensitivity and abnormal motor responses along with change in gut habits. Although the etio-pathogenesis of IBS is only partially understood, a main role has been attributed to psychosocial stress of different origin. Animals models such as neonatal maternal separation, water avoidance stress and wrap restraint stress have been developed as psychosocial stressors in the attempt to reproduce the IBS symptomatology and identify the cellular mechanisms responsible for the disease. The study of these models has led to the production of drugs potentially useful for IBS treatment. This review intends to give an overview on the results obtained with the animal models; to emphasize the role of the enteric nervous system in IBS appearance and evolution and as a possible target of drug therapies.


2019 ◽  
Vol 3 (1) ◽  
Author(s):  
Eduardo E. Valdez-Morales ◽  
Tonatiuh Barrios-García ◽  
Alma Barajas-Espinosa ◽  
Raquel Guerrero Alba

2021 ◽  
Vol 33 (3) ◽  
Author(s):  
Lars Wilmes ◽  
James M. Collins ◽  
Kenneth J. O'Riordan ◽  
Siobhain M. O’Mahony ◽  
John F. Cryan ◽  
...  

2012 ◽  
Vol 1 ◽  
pp. 123-129 ◽  
Author(s):  
Majid Mahvi-Shirazi ◽  
Ali Fathi-Ashtiani ◽  
Sayed-Kazem Rasoolzade-Tabatabaei ◽  
Mohsen Amini

Sign in / Sign up

Export Citation Format

Share Document